Alcohol consumption and heart failure in hypertensives

J O Olubodun1, S O Lawal

  • 1Department of Medicine, Ogun State University and Teaching Hospital, Shagamu, Nigeria.

Insights

Heavy alcohol consumption significantly contributes to heart failure in hypertensive patients. This study found a strong association between excessive drinking and the development of heart failure among individuals with hypertension.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Public Health

Background:

  • Hypertension is a prevalent condition, often coexisting with other cardiovascular issues.
  • The role of lifestyle factors, such as alcohol consumption, in the progression of hypertension and development of heart failure requires further investigation.

Purpose of the Study:

  • To assess alcohol consumption patterns in hypertensive patients with and without heart failure.
  • To determine the association between heavy alcohol intake and the incidence of heart failure in this population.

Main Methods:

  • A case-control study involving 60 hypertensive patients (30 with heart failure, 30 without), matched for age and sex.
  • Assessment of alcohol consumption habits, including quantity and duration.
  • Comparison of alcohol intake between the heart failure and non-heart failure groups.

Main Results:

  • Heavy alcohol consumption was significantly more prevalent in the heart failure group (75%) compared to the non-heart failure group (18.2%).
  • Nine patients (30%) in the heart failure group and two (6.7%) in the non-heart failure group consumed >= 80g of alcohol daily for at least 3 years (P < 0.02).
  • The odds ratio for heavy alcohol consumption was 5.9, suggesting a strong link to heart failure.

Conclusions:

  • Heavy alcohol consumption is a significant contributing factor to heart failure in hypertensive patients.
  • Findings highlight the importance of screening for and addressing heavy alcohol use in managing hypertension and preventing heart failure.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.